Skip to main content
. Author manuscript; available in PMC: 2021 Jul 30.
Published in final edited form as: Nat Prod Rep. 2021 May 26;38(5):880–889. doi: 10.1039/d0np00052c

Scheme 3.

Scheme 3

Substrate-controlled IMDA syntheses: (a) Opatz’s total synthesis of (−)-hymenosetin (4);28 (b) Williams’ total synthesis of (+)-apiosporamide (5);30 (c) Tadano’s total synthesis of (+)-tubelactomicin A (12);32,33 (d) Kalesse’s total synthesis of (−)-chlorotonil A (13).35

HHS Vulnerability Disclosure